Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
about
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunityExtracellular matrix proteins and displacement of cultured fibroblasts from duodenal biopsies in celiac patients and controlsA new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literatureUpdate on the medical treatment of Graves' ophthalmopathyBenzylideneacetophenone derivatives attenuate IFN-γ-induced IP-10/CXCL10 production in orbital fibroblasts of patients with thyroid-associated ophthalmopathy through STAT-1 inhibition.Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis)Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in TaiwanMeta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.Graves' ophthalmopathy: a review of immunogenetics.Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathyRelevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassayIsolation and culture of fibroblasts from endoscopic duodenal biopsies of celiac patients.Immune mechanisms in thyroid eye disease.Allosteric modulators hit the TSH receptor.The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Critical involvement of the hinge region of the follicle-stimulating hormone receptor in the activation of the receptor.Shopping for doctors: Thyroid eye disease patients are never satisfied.The influence of hepatitis C infection and interferon-alpha therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case reportGenetic variations in the SOCS3 gene in patients with Graves' ophthalmopathy.Computer-Assisted Three-Dimensional Planning for Orbital Decompression.Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder.Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy.RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy.Thyroxine, shape, and weight: interaction of Graves' disease and bulimia nervosa.Measurement of Orbital Biomechanical Properties in Patients with Thyroid Orbitopathy Using the Dynamic Scheimpflug Analyzer (Corvis ST).
P2860
Q26852013-10411FA4-61A1-4CA1-B6EC-22D41281FAD9Q30539211-765BAD77-BC61-42CF-BFBF-E5DC7B724A2BQ30932002-3605476F-5249-4593-8875-CC729FEDC89DQ33735061-E5DFF545-22C8-46EA-8D7E-64D7B8F80118Q33844846-E7CE05B0-7E21-4170-B07A-B2BB40A2BACCQ34130987-985BF5CA-230D-4693-ADB0-C5FE0EE68DBFQ34467124-06768517-9421-47B5-98EF-AEF0FB732150Q34525298-3D2F9349-FE28-4FC8-9D80-02AB60BF5FD2Q35092083-2480803E-2BCC-41B5-97D4-DD744191D7DCQ35547833-B5B96516-9C55-4794-AC77-93820971AEA6Q35671939-5F9F312F-1E8B-42DA-9D1B-D313AE19D3E4Q35731002-D0D661A8-A455-4A04-A818-56A7DF11217BQ35904885-98B33C77-79FA-451A-901F-86B31D6D2554Q36070800-9F5722A6-8BE7-45FD-BB9A-10F617270076Q36444611-26EF3970-0A1D-4DE2-8A26-17405C9E3C41Q36872831-6EE96132-D3DC-4741-A7BB-D7716744214AQ37087157-1162EB7E-65E3-4C6E-BFE4-9438E2B3E25FQ37224943-83D3F81D-35A4-407A-8CE0-6C711F15ABAAQ37254482-421E7ED5-73FD-409D-9A67-89FE6560314BQ37405149-56AFBC1B-98A1-43E9-B5C5-849582BBA288Q37784810-5C5F28A0-451D-46AA-B838-B866F31E0213Q38633022-0956F955-D1FF-4F84-9752-7ACB865408D8Q39912851-9B29519F-F547-4186-9A70-70CBC25677C2Q40567245-F0E33FE0-F042-4973-BE36-FA3DBAFD14B6Q41822662-5618210A-394F-4F1C-8FC3-0702D6A2C977Q42155017-719B8BDF-9509-4C2A-8D69-24F03A4026DBQ42433372-B9BC657E-8501-4DC6-9C4E-C2969B8D9276Q42801091-16C2DD0F-E168-4CB8-9D53-ECA093553B7DQ43124440-A293318C-094F-45CE-A0AE-A23F1B5B36B0Q45897216-FBD8A2B1-B1E6-44F2-8AEE-E4B12506E1E0Q47121440-1F122742-E86B-4394-AE52-90DD84B3A1A8Q47229903-23D285BC-D6C9-4191-9613-8822CF57FDBAQ47323119-406C82EF-923A-4F4C-8466-C9E789310DE2
P2860
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
@en
type
label
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
@en
prefLabel
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
@en
P2860
P356
P1433
P1476
Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.
@en
P2093
Rebecca S Bahn
Teck Kim Khoo
P2860
P304
P356
10.1089/THY.2007.0185
P577
2007-10-01T00:00:00Z